Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

J&J files three-monthly schizophrenia drug in Europe

J&J files three-monthly schizophrenia drug in Europe over other once-monthly rivals such as Lilly's Zypadhera (olanzapine) and Lundbeck's Abilify Maintena (aripiprazole), launched in Europe last year.

Lundbeck to cut 1,000 jobs in major restructure

Lundbeck to cut 1,000 jobs in major restructure Lundbeck's focus will now turn more to its newer drugs such as Brintellix (vortioxetine), Northera (droxidopa), Onfi (clobazam) and Abilify Maintena (aripriprazole) which saw a 190% growth in sales. .

Lundbeck and Otsuka's Rexulti set for August launch in US

Lundbeck and Otsuka's Rexulti set for August launch in US Rexulti (brexpiprazole) is a dopamine D2 and serotonin 5-HT1A partial agonist positioned as a successor to the Otsuka's big-selling atypical antipsychotic Abilify (aripiprazole), which is sold by ... Abilify's primary use is in schizophrenia and bipolar

Ten new medicines recommended in Europe

Ten new medicines recommended in Europe This is a copycat version of Bristol-Myers Squibb/Otsuka's blockbuster Abilify (aripiprazole), which made $5.5bn last year, but is now starting to succumb to generic erosion.

Pfizer maintains lead in top CNS drug sales - just

Pfizer maintains lead in top CNS drug sales - just Otsuka's anti-psychotic drug Abilify (aripiprazole), which the company co-markets with Bristol-Myers Squibb, was once the sales leader in the CNS arena but it is now being hit

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics